Evidence map›Paper›PMID 29226133›Full record

ArticleBioMed research international2017

Circulating Interferon-

Alicja E Grzegorzewska, Monika K Świderska, Adrianna Mostowska, Paweł P Jagodziński

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alicja E GrzegorzewskaChair and Department of Nephrology, Transplantology and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0001-8087-4696
Monika K ŚwiderskaStudent Nephrology Research Group, Chair and Department of Nephrology, Transplantology and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0002-6210-6420
Adrianna MostowskaDepartment of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0003-4181-9402
Paweł P JagodzińskiDepartment of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0002-9046-6802
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The IFN-

Indexed as

AdultAgedAged, 80 and overAntiviral AgentsCross-Sectional StudiesFemaleGenotypeHepacivirusHepatitis BHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B VaccinesHepatitis B virusHepatitis CHumansInterferonsAntiviral AgentsHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B VaccinesInterferons

Identifiers

PMID29226133
PMCPMC5684519
OpenAlexW2766804593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.